Peer Review History
| Original SubmissionOctober 4, 2021 |
|---|
|
PONE-D-21-31719Vaccine discourse during the onset of the COVID-19 pandemic: Thematic structure and source patterns informing efforts to combat vaccine hesitancyPLOS ONE Dear Dr. Hwang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jan 16 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kazutoshi Sasahara Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. Additional Editor Comments: Both reviewers think the manuscript is important, but they also think that it needs more improvements. Please read the comments carefully and address them in the revised paper. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This is a strong study that provides important insights into communication flows on Twitter during the early part of the COVID pandemic. It shows key differences between negative and positive sentiment through a comprehensive analysis (i.e., using multiple methods) of original tweets. The methods are sound, and findings support the conclusions. There also is real value here for public health communication. My main recommendation is to tighten and revise the structure of the article in order to clearly draw out the core insights and to show why these methods are required to generate those insights. In the "Descriptive" section, it is somewhat difficult for the reader to understand how each part of this sequentially presented analysis builds to the article's findings and main argument. Why, for example, does this section of the article start by tracking the volume of tweets? What does this tell us about COVID communication flows that will be integral to the study's main argument? Each of these sections in the "Descriptive" section should be introduced with a clear statement of why the authors are choosing to, in order, analyze: 1) Volume of tweets 2) Prevalence of topics 3) Topic communities 4) Relative volume of topics over time 5) Distinct topical prevalence, positive vs. negative valence 6) Same as 5, but in relationship to hashtags 7) Mention network 8) Mention by account type In other words, this is a richly detailed analysis that needs to be strung together in a more coherent fashion that, in each case along the way, builds and supports a clear argument based on the findings. More generally, the findings need to be more closely stitched together with the very clear enumeration of issues of 1) content, and 2) actors on pp. 27-28. Revising the article to support, step-by-step, this dual focus on content and actors will help bring more coherence to the methods and findings. It also would be nice to see a concise, brief summary of the study's three principal takeaways in the first paragraph of the Discussion. This could be one or two sentences following the mention of topics and actors, which then would lead into the more detailed elaborations of each individual finding below. Also helpful for maximizing the article's impact would be noting present public health communication strategies designed to counter vaccine hesitancy. These could be added to the introduction's literature review, and they would help clarify what is new about the author's conclusions and recommendations for improving these strategies and developing new strategies. A few other issues: The authors use the terms "themes," "thematic patterns," and "topics" interchangeably. I suggest sticking to a single term, such as "topic," unless there is a distinction between themes and topics that is important to the study. If so, this distinction needs to be clarified. The methods arise in mid-paragraph on p. 5. All references to methods to be contained in the methods section. Something is missing in the first sentence on p. 17. "To understand how the discourses" what? In Footnote 3 on p. 20, please clarify that @realdonaldtrump is former President Trump's Twitter account. As it now reads, "his" is a pronoun without a first reference. p. 11: Figure 1 has a typo in the title: "Volumn" p. 23: "Principle findings" should be "Principal findings" p. 24 and p. 29: the term "anti-vaxxers" is used here, without definition, though the term implies that all of these social media users were actively opposed to vaccinations. However, we know that there is a range of negative vaccine sentiments, from hesitancy and doubt, to criticism and outright opposition. Accordingly, the literature in this area tends to invoke a spectrum of vaccine confidence (see Larson, 2020; MacDonald the SAGE Working Group on Vaccine Hesitancy, 2015), and the authors open the article by referring to this spectrum. It then is confusing why the term "anti-vaxxers" appears at this point in the article. Please clarify or revise the terminology to align with the article's introduction. Reviewer #2: Overall The general area of research is topical. Overall I don't find this paper compelling, partly due to the methods, and partly due to the execution. I am not an expert in STM, so I cannot comment on that. If they could do the paper without machine classification, I think it would be improved, as I don't think these methods are successful on Twitter data--based on their results and my personal experiences. Major comments I have done extensive work using machine learning and Twitter, and have never published it because the results are always disappointing. My experience is that 140 characters is not sufficient for proper classification of most Twitter content. The authors used a machine learning method that has, in my view, high error, reporting only 71% and 75% accuracy. The ROC curves in vaccine 3 confirms fairly high combined error tradeoff between sensitivity and specificity. The fact that that 20-30% of the content is coded wrong should cause the authors to be very cautious in the interpretation of their results, and I think presents a serious challenge to publishing this paper. The use of regression models in analyzing an outcome with large measurement error (Table 2) is especially problematic. I don't know much about structural topic modelling, but these kinds of approaches are more effective when there is more text available. Again, Twitter data presents a challenge here; gathering a meaning from small quantities of text is hard. However, since i am not an expert in this method, I cannot comment further. Finally, I don't see the practical implications of the paper. The authors claim that "our results highlight the type of content that needs to be addressed to improve vaccine hesitancy" but offer no actual evidence of this. This is a desscriptive paper that does not drill into what imapats vaccine hesitancy. Moreover, changes in attitudes towards covid-19 vaccines render some of these findings somewhat obsolete; what concerns people today (in late 2021) may be different from what concerned them early in vaccine uptake. Minor comments Page 4 "social media content does not undergo an editorial processes or scientific vetting". This statement is not true. Twitter, Facebook and YouTube implemented editorial controls specific to Covid and vaccination in 2020. Page 6. Is the use of Synthesio and web scraping of Twitter legal? Is the use of this tool covered under fair use legislation/practice? Do we know that Synthesesio actually generates true and unbiased samples? Was this service paid for by the authors? Details here are important for the reader for a number of reasons. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-21-31719R1Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancyPLOS ONE Dear Dr. Hwang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Apr 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kazutoshi Sasahara Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: Both reviewers think that the manuscript has been improved, but they also think that it needs minor revisions. Please revised based on the comments. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have improved the readability of the article by providing effective subheadings, by more strongly emphasizing the two-fold nature of the analysis (content/actors), and by including additional cites and cautions regarding the methods. I do think that these methods are appropriate for Twitter analysis, though they must be presented with caution, as the authors do. My only remaining question concerns the authors' recommendation of paying for the promotion of content among vaccination hesitant Twitter users, as I am unclear of ethics considerations or other potential concerns surrounding such an intervention. Are there cites that could be included to support this recommendation or at least to point out relevant debates concerning it? Reviewer #3: Authors explore public discourse about covid 19 via random sample of twitter and analyzed using Structural Topic Modeling and Network Analysis. I am satisfied by most of responses provided by the authors on the reviewes. However, I would argue that authors still need to highlight/defend their selection of methods. Since this same study can be conducted using multiple methods in unsupervised learning, and there is much research available for this as well, it is important that authors explain their strategy of selecting this method. I,e sentiment could also capture using other NLP methods, authors may have a reason to use the ML model instead. At the same time, it would be helpful to know how did you ended up 2 coders, and were they experienced researchers or external from this study – this will help up to navigate the validity of the codes. I am not sure how did authors classify the mention network into several subjects – were these done by authors? 1 author? inductively or deductively? Topical associate represents in the figure 3 needs bit more details – how the association was derived between topics. May be one example to reflect the association would be more helpful to the reader. Near the figure 4 where authors present the temporal volume, authors state “…While some topics received more sustained overtime attention (e.g., Topic 6 – Conspiracy Theory), others showed a higher degree of fluctuation in Twitter volume (e.g., Topic 8 – Vaccine Development).” – It is not possible to derive this statement from figure 4, it should be explained using figure 3 and it need to bring the connection to figure 4. Figure 6 is not words its #tags right, ( words can be misunderstood as words in the topic,but this not the case right? - “Words featuring most prominently in positive versus negative vaccine discourses”.. Besides word cloud seems not much providing the context to what authors trying to explain in this. So its more taking space without much value. Overall, I also felt the need of the coherent story and the key findings in the discussions and authors somewhat have addressed that, but this is still could be improved. Overall, I enjoyed the implication part the most, which is the essence of this this contribution, and with that I think this paper has a substantial value to the journal. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
PONE-D-21-31719R2Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancyPLOS ONE Dear Dr. Hwang, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers agreed that the manuscript was improved. But one reviewer required a few minor revision. you Please read comments and address accordingly. Please submit your revised manuscript by Aug 05 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-emailutm_source=authorlettersutm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Kazutoshi Sasahara Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This article is much improved and, in my view, needs only a couple minor revisions: On p. 10: Should "Sandford" be "Stanford"? p. 25: The authors indicated in their responses to reviewer comments that they had removed references to paying for promotion of content, yet this sentence remains in the article: "Again, paid sponsorship of influencers accounts may prove to be an effective intervention strategy." Do they still intend to include such recommendations? Reviewer #3: I thank the authos for addressing my comments in the manuscript and also explaining in the response letter. New changes appearing much improved and clear decription of the conduct and results and the story behind the results. I think the insights will bring much value to the readers. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: Yes: Dilrukshi Gamage ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy PONE-D-21-31719R3 Dear Dr. Hwang, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Kazutoshi Sasahara Academic Editor PLOS ONE Additional Editor Comments (optional): Now all the reviewers think it's properly revised. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-31719R3 Vaccine discourse during the onset of the COVID-19 pandemic: Topical structure and source patterns informing efforts to combat vaccine hesitancy Dear Dr. Hwang: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Kazutoshi Sasahara Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .